share_log

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Ribeiro Ramiro

SEC announcement ·  Mar 5 06:46
Summary by Futu AI
EyePoint Pharmaceuticals, Inc. (EYPT) has reported a transaction involving Chief Medical Officer Ramiro Ribeiro. The transaction took place on March 1, 2024. However, the announcement did not disclose the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Ribeiro after the transaction was not provided. Investors are advised to seek further details on the transaction to better understand its impact on their investment decisions.
EyePoint Pharmaceuticals, Inc. (EYPT) has reported a transaction involving Chief Medical Officer Ramiro Ribeiro. The transaction took place on March 1, 2024. However, the announcement did not disclose the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Ribeiro after the transaction was not provided. Investors are advised to seek further details on the transaction to better understand its impact on their investment decisions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.